Skip to content

VITROS 1149764Recalls & reported problems

Ortho-Clinical Diagnostics, Inc. · VITROS Chemistry Products Calibrator Kit 5 · Class 2

Data updated Oct 13, 2026 from official FDA records · Editorial policy

Adverse event reports
3
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 10758750008483), received between Mar 15, 2023 and Mar 23, 2026 — classified as 3 malfunctions.

The most frequently reported specific device problem is “High Test Results” (3 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 1 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 1 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • High Test Results3
  • Low Test Results1

Patient problems

  • No Clinical Signs, Symptoms or Conditions3

Recent adverse event reports

The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.

  • MalfunctionMar 23, 2026High Test Results

    A CUSTOMER CONTACTED THE ORTHO CLINICAL DIAGNOSTICS (ORTHO) TECHNICAL SOLUTION CENTER (TSC) TO REPORT A HIGHER THAN EXPECTED RESULT ABOVE THE VITROS AMON MEASURING RANGE OF 8.7 - 500 UMOL/L OBTAINED FROM A SINGLE PATIENT SAMPLE USING VITROS AMMONIA (AMON) SLIDE LOT 1020-0268-5975 ON A VITROS 4600 CHEMISTRY SYSTEM. PATIENT SAMPLE VITROS AMON RESULT OF >500 UMOL/L VS. THE EXPECTED RESULT OF 102 UMOL/L. BIASED RESULTS OF THE MAGNITUDE AND DIRECTION OBSERVED MAY LEAD TO INAPPROPRIATE PHYSICIAN ACTION IF THEY WERE TO OCCUR UNDETECTED. THE HIGHER THAN EXPECTED VITROS AMON RESULT WAS NOT REPORTED OUTSIDE THE LABORATORY AND THERE WAS NO ALLEGATION OF PATIENT HARM. THIS REPORT CORRESPONDS TO ORTHO CLINICAL DIAGNOSTICS INC (ORTHO) COMPLAINT NUMBER (B)(4) AND REPORTABILITY ASSESSMENT 613873.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 24664765 ↗
  • MalfunctionOct 22, 2024High Test Results; Low Test Results; High Test Results; Low Test Results

    A CUSTOMER CONTACTED THE ORTHO CLINICAL DIAGNOSTICS (ORTHO) TECHNICAL SOLUTION CENTER (TSC) TO REPORT LOWER AND HIGHER THAN EXPECTED RESULTS WERE OBTAINED FROM TWO DIFFERENT LEVELS OF NON-VITROS BIORAD ETHANOL/AMMONIA CONTROLS, LOT 54390, USING VITROS AMMONIA (AMON) SLIDE LOTS 1019-0266-5803 AND SLIDE LOT 1020-0265-0764 ON A VITROS 4600 CHEMISTRY SYSTEM. VITROS AMON REAGENT SLIDE LOT 1020-0265-0764: BIORAD LEVEL 2 AMON RESULTS OF 61.71, 63.51, 112.45, 68.28, 70.84, 68.46, AND 62.67 ?MOL/L VS. THE EXPECTED RESULT OF 92.88 ?MOL/L BIORAD LEVEL 3 AMON RESULTS OF 187.76 ?MOL/L VS. THE EXPECTED RESULT OF 239.90 ?MOL/L VITROS AMON REAGENT SLIDE LOT 1019-0266-5803: BIORAD LEVEL 2 AMON RESULTS OF 122.83, 113.59, 72.81, AND 59.75 ?MOL/L VS. THE EXPECTED RESULT OF 92.40 ?MOL/L BIORAD LEVEL 3 AMON RESULTS OF 184.23 ?MOL/L VS. THE EXPECTED RESULT OF 242.10 ?MOL/L LIQUID PERFORMANCE VERIFIER II AMON RESULTS OF 129.17, 142.36, 143.74, 145.21, 145.97, 148.40, 149.81, 150.95, 152.00, 152.40, 153.53 AND 154.35 ?MOL/L VS. THE EXPECTED RESULT OF 194.70 ?MOL/L AFTER SERVICE INTERVENTIONS USING VITROS AMON REAGENT SLIDE LOT 1019-0266-5803: BIORAD LEVEL 2 AMON RESULTS OF 115.40, 115.04, AND 112.20 ?MOL/L

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 20509679 ↗
  • MalfunctionMar 15, 2023High Test Results; High Test Results

    A CUSTOMER CONTACTED THE ORTHO CLINICAL DIAGNOSTICS (ORTHO) TECHNICAL SOLUTION CENTER (TSC) TO REPORT HIGHER THAN EXPECTED VITROS AMMONIA (AMON) RESULTS WERE OBTAINED FROM A NON-VITROS BIORAD QUALITY CONTROL FLUID PROCESSED USING VITROS CHEMISTRY PRODUCTS AMON SLIDES LOT 1019-0259-0222 ON A VITROS 5600 INTEGRATED SYSTEM. BIORAD CONTROL LOT 54360 LEVEL 2 VITROS AMON RESULTS OF 126.9, 123.0 AND 120.8 UMOL/L VERSUS AN EXPECTED RESULT OF 93.1 UMOL/L BIASED RESULTS OF THE MAGNITUDE AND DIRECTION OBSERVED MAY LEAD TO INAPPROPRIATE PHYSICIAN ACTION IF THEY WERE TO OCCUR UNDETECTED ON PATIENT SAMPLES. THE HIGHER THAN EXPECTED VITROS AMON RESULTS WERE OBTAINED WHEN PROCESSING A CONTROL FLUID. NO RESULTS WERE REPORTED OUT OF THE LABORATORY AND THE CUSTOMER MADE NO INDICATION THAT PATIENT SAMPLE RESULTS WERE AFFECTED OR QUESTIONED. ORTHO WAS NOT MADE AWARE OF ANY ALLEGATION OF PATIENT HARM AS A RESULT OF THIS EVENT. THIS REPORT CORRESPONDS TO ORTHO CLINICAL DIAGNOSTICS INC (ORTHO) COMPLAINT NUMBER (B)(4) AND REPORTABILITY ASSESSMENT (B)(4).

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 16547962 ↗

Other BROMCRESOL GREEN DYE-BINDING, ALBUMIN devices

All BROMCRESOL GREEN DYE-BINDING, ALBUMIN devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page